EUVIMEDEUVIMED entdecken
Crossref

Development and Evaluation of Anti-Acne Transdermal Patches: A Novel Approach to Targeted Drug Delivery

Archana Gorakshnath Alhat, Dilnawaz Ahmed Nazeer Ahmed Pathan, Vrushant Sudhir Pise, Hrishikesh Madhukar Lawate, Divya Bhausaheb Phadatare, Shantanu Chandarkant Jagtap, Sanjay Ravindra Chaudhari

International Journal of Drug Delivery Technology · 25.04.2026 · 16 (22s)

DOI: 10.25258/ijddt.16.22s.20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Archana Gorakshnath Alhat und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acne vulgaris is a chronic inflammatory dermatological condition affecting approximately 85% of adolescents and young adults worldwide, representing a significant public health burden. Conventional therapies, including oral antibiotics and topical retinoids, are associated with systemic side effects, antibiotic resistance, and poor patient compliance. This study reports the development, formulation, and comprehensive evaluation of herbal anti-acne transdermal patches incorporating three bioactive phytochemicals: Allicin (extracted from Allium sativum), Arecolinerich extract from Areca catechu, and Aloe vera gel. Four patch formulations (F1–F4) were prepared using a solvent casting technique employing HPMC and Carbopol 934 (3:1) as the polymer matrix, with propylene glycol (30%) as a penetration enhancer. Physicochemical evaluation parameters including thickness (0.127–0.146 mm), folding endurance (180–200 folds), moisture content (8.2–8.8%), and drug content were assessed. In vitro drug release studies using a Franz diffusion cell with eggshell membrane demonstrated sustained release profiles, with formulation F4 (containing 2.0 mL Allicin) exhibiting the highest drug permeation and a 26.1% cumulative release at 10 minutes, followed by sustained controlled release. Antimicrobial activity testing against Propionibacterium acnes revealed significant zones of inhibition. Molecular docking studies confirmed that Allicin binds to the bacterial surface protein PA25957 (binding energy: −5.5 kcal/mol) and Arecoline interacts with Retinoid X receptor alpha (RXRα) to suppress sebum production and keratinocyte proliferation. Skin irritation testing demonstrated excellent biocompatibility with no observable irritation. These results indicate that the herbal transdermal patch represents a promising, safe, and effective alternative to conventional acne therapies, offering targeted drug delivery with minimal systemic exposure.

Zitieren

APA

Alhat, A. G., Pathan, D. A. N. A., Pise, V. S., Lawate, H. M., Phadatare, D. B., Jagtap, S. C., & Chaudhari, S. R. (2026). Development and Evaluation of Anti-Acne Transdermal Patches: A Novel Approach to Targeted Drug Delivery. International Journal of Drug Delivery Technology, 16(22s). https://doi.org/10.25258/ijddt.16.22s.20

Vancouver

Alhat AG, Pathan DANA, Pise VS, Lawate HM, Phadatare DB, Jagtap SC, et al. Development and Evaluation of Anti-Acne Transdermal Patches: A Novel Approach to Targeted Drug Delivery. International Journal of Drug Delivery Technology. 2026;16(22s). doi:10.25258/ijddt.16.22s.20

BibTeX
@article{Alhat2026,
  author = {Alhat, Archana Gorakshnath and Pathan, Dilnawaz Ahmed Nazeer Ahmed and Pise, Vrushant Sudhir and Lawate, Hrishikesh Madhukar and Phadatare, Divya Bhausaheb and Jagtap, Shantanu Chandarkant and Chaudhari, Sanjay Ravindra},
  title = {Development and Evaluation of Anti-Acne Transdermal Patches: A Novel Approach to Targeted Drug Delivery},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {22s},
  doi = {10.25258/ijddt.16.22s.20}
}
Kostenlos starten →